Literature DB >> 6450019

Disparate effects of methyldopa and clonidine on cardiac mass and haemodynamics in rats.

S Ishise, B L Pegram, E D Frohlich.   

Abstract

1. Wistar-Kyoto and spontaneously hypertensive rats were given either methyldopa (400 mg day-1 kg-1) or clonidine (0.1 or 0.3 mg day-1 kg-1) for 3 weeks commencing at 20 weeks of age. 2. Both drugs significantly decreased mean arterial pressure in spontaneously hypertensive but not Wistar-Kyoto rats. Heart rate was significantly increased in spontaneously hypertensive rats by methyldopa, whereas clonidine significantly decreased heart rate. The higher dose of clonidine also decreased heart rate in Wistar-Kyoto rats. Both cardiac output and total peripheral resistance decreased slightly, but not significantly, with both agents. 3. Methyldopa, but not the lower equipotent depressor dose of clonidine, reduced left ventricular hypertrophy in spontaneously hypertensive rats. However, the higher dose of clonidine also significantly decreased the heart to body weight ratio despite an increased total peripheral resistance presumably due to the alpha-adrenergic agonist effect. 4. Minimal changes in organ blood flows were noted with both drugs. 5. These results suggest that neither systemic haemodynamics nor central inhibition of adrenergic drive are primary factors responsible for the regression of hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6450019     DOI: 10.1042/cs059449s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  Ventricular performance in spontaneously hypertensive rats (SHR) with reduced cardiac mass.

Authors:  T Natsume; M B Kardon; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

2.  Hypertension research program at ochsner: a program in translational research.

Authors:  Edward Frohlich
Journal:  Ochsner J       Date:  2002

3.  Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study.

Authors:  J Szlachcic; W D Hall; J F Tubau; V Porter; C Vollmer; G Wollam; A Hirsch; B Massie
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

4.  Left ventricular hypertrophy regression during antihypertensive treatment.

Authors:  H Eichstaedt; O Danne; R J Schroeder; D Kreuz
Journal:  Clin Investig       Date:  1992

5.  Immediate and prolonged hemodynamic effects of TA-3090 on spontaneously hypertensive (SHR) and normal Wistar-Kyoto (WKY) rats.

Authors:  T Isshiki; B L Pegram; E D Frohlich
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.